“Roche’s Latest EMBARK Findings: Elevidys Proves Powerful for Duchenne Muscular Dystrophy Patients on the Move!”

Roche Announces Positive Results from Year Two of EMBARK Trial A Game-Changer in the Treatment of Duchenne Muscular Dystrophy Basel, 27 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive topline results from year two of the EMBARK trial, a global, randomised, double-blind phase III study of Elevidys™ (delandistrogene moxeparvovec), the first…

Read More

Consumers’ Choice Awards 2024: Celebrating Excellence and the Voice of the Consumer

The excitement was palpable as the sixth edition of the Consumers Choice Awards was launched on Friday at the prestigious Golf Course Hotel in Kampala Organized by Consumers Guide Magazine (CGM), these awards have become a hallmark of excellence, celebrating businesses that consistently deliver outstanding service and value as recognized by their customers The Chief…

Read More

Levi & Korsinsky Urges Shareholders: Don’t Miss Your Chance to Lead a Significant Securities Class Action – Important Deadline Approaching

Understanding Your Rights as a Walgreens Boots Alliance, Inc. Investor: A Comprehensive Guide If you have recently experienced a financial loss after investing in Walgreens Boots Alliance, Inc. (WBA) and wish to explore potential recovery options under federal securities laws, this article is designed to provide you with valuable insights and guidance. About the Walgreens…

Read More